Lymphoma

New Factor In The Development Of Childhood Lymphoma

The immune system is highly complex and a detailed understanding of many underlying mechanisms is still lacking. Only the precise interaction of a variety of factors guarantees a reliable and correct immune response in a healthy body. Misregulated...

Read More →

Roche's Gazyva Now A Breakthrough Therapy For Lupus Nephritis

Roche RHHBY announced that the FDA has granted Breakthrough Therapy designation (BTD) to its lymphoma drug Gazyva (obinutuzumab) for a new indication.The agency granted BTD to the drug based on data from the phase II NOBILITY study in adult patients...
Related topics: Lupus, Food And Drug Administration, Medical Research

Read More →

Radiation May Lower Potential For Side Effects Of Car T Therapy In Non-hodgkin's Lymphoma

Treating non-Hodgkin's lymphoma (NHL) patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side effects once it is administered.

Read More →

Dear Mark: Does Chicken Cause Cancer, Should You Neuter, Dog Collagen, And Skipping Dinner

For today’s edition of Dear Mark, I’m answering a few questions. First came in from an email and regards a new study showing a link between chicken eating and several types of cancers (melanoma, prostate cancer, non-Hodgkin’s...
Related topics: Cancer, Prostate Cancer, Skin Cancer, Oncology, Medical Research, Melanoma

Read More →

Medicare To Cover Car-t Therapy For Leukemia, Lymphoma

THURSDAY, Aug. 8, 2019 -- A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says. Chimeric antigen receptor T-cell (CAR-T) therapy boosts a patient's own immune cells to fight cancer and can cost...
Related topics: Medicare, Leukemia, Genetics, Cancer, Oncology

Read More →

Health Highlights: Aug. 8, 2019

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Medicare to Cover Breakthrough Gene Therapy for Leukemia, Lymphoma A breakthrough gene therapy will be covered for certain types of lymphoma...
Related topics: Medicare, Genetics, Leukemia

Read More →

Prima: Long-term Pfs And Os In Follicular Lymphoma

(MedPage Today) -- Rituximab maintenance produced a 6-year PFS benefit, but the same OS as observation

Read More →

Researchers Make Immunotherapy Work For Treatment-resistant Lymphoma

Researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically increased the success of the...
Related topics: Medical Research, Stem Cells

Read More →

Aiming To Identify New Prognostic Markers For Childhood Hodgkin Lymphoma

A Rutgers Cancer Institute of New Jersey pediatric hematologist/oncologist has received a $50,000 grant from the Children's Oncology Group Foundation to help identify new prognostic markers and potential therapeutic targets in pediatric Hodgkin...
Related topics: Cancer, Oncology, Hematology

Read More →

Allergan Recalls Textured Breast Implants Linked To Rare Cancer

More than 500 cases of implant-associated lymphoma have been linked to textured implants worldwide, and most of the implicated devices were made by Allergan, the FDA said.
Related topics: Breast Cancer, Cancer, Oncology, Food And Drug Administration

Read More →

Bills Dt Kyle Peko Reports To Training Camp As Wife Battles Stage 3 Hodgkin's Lymphoma

The wife of Bills DT Kyle Peko is battling stage 3 Hodgkin's lymphoma. He missed the first day of training camp, but returned to the team Thursday.       

Read More →

Pediatric Lymphoma Joins Family Of Brca2 Cancers

Researchers call for genetic testing of all survivors of pediatric non-Hodgkin lymphoma after data revealed BRCA2 is implicated in the childhood disease. Medscape Medical News
Related topics: Cancer, Oncology, Medical Research, Genetics

Read More →

Fda: Allergan Should Pull Some Breast Implants

(MedPage Today) -- Risk of rare lymphoma six times more common with company's textured implants
Related topics: Food And Drug Administration

Read More →

Asct May Offer Alternative For Tx Of High-risk Follicular Lymphoma

THURSDAY, July 25, 2019 -- Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, according to a study published online...
Related topics: Stem Cells, Medical Research

Read More →

Inherited Brca2 Mutations Linked To Increased Risk Of Childhood Lymphoma

A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents. The work appears as an advance online publication today in JAMA...
Related topics: Genetics, Medical Research, Cancer, Oncology

Read More →

Researchers Unveil Experimental Compound To Block Therapeutic Target In Blood Cancer

Researchers have discovered a hyperactive cell signal that contributes to tumor growth in primary effusion lymphoma, an aggressive type of non-Hodgkin lymphoma caused by infection with the Kaposi's sarcoma-associated herpesvirus (human...
Related topics: Medical Research, Cancer, Oncology

Read More →

Seattle Genetics Hits Its Second Growth Phase

After a slow start to 2019, Seattle Genetics (NASDAQ: SGEN) picked up the pace in the second quarter, with doctors increasing their use of Adcetris early in the treatment paradigm for various types of lymphoma.MetricQ2 2019Continue reading
Related topics: Genetics, Nasdaq

Read More →

Steelers' James Conner Reveals Details About Cancer Diagnosis: 'you Had About A Week...

Pittsburgh Steelers running back James Conner was told by doctors, "you had about a week left" before they discovered his Hodgkin's Lymphoma.       
Related topics: Cancer, Oncology, Medical Research

Read More →

High Doses Of 60 Plus-year-old Chemo Drug Found To Spur Immune System Attack On Lymphoma

Cyclophosphamide, a mainstay of chemotherapy for many cancers, acts as both chemotherapy and immunotherapy at high doses, study finds.
Related topics: Chemotherapy, Cancer, Oncology, Medical Research

Read More →

Immunotherapy-chemo Combo Based On Work Of Roswell Park's Dr. Ben Seon Gets Fda Approval

A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration (FDA) for patients with an aggressive form of non-Hodgkin lymphoma.
Related topics: Chemotherapy, Cancer, Food And Drug Administration, Oncology

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.